Skip to main content

Figure 1.

Figure 1

Echocardiographic findings with primary and secondary end-points. (A) Mean ejection fraction improves from 35 ± 6.1% to 50 ± 8.8% at 6 months post treatment of sacubitril/valsartan. (B) Echocardiographic follow up showed consistent reduction of chamber size including LVEDd, LVEDs, and LAD. The p values were tested for comparison of baseline and final assessment. LAD, left atrial diameter; LVEDd, left ventricular end-diastolic diameter; LVEDs, left ventricular end-systolic diameter.